Atlas Trials

Efficacy and Safety of Divozilimab in Patients With Neuromyelitis Optica Spectrum Disorders (AQUARELLE)

Clinical trial NCT05730699 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05730699
Sponsor
Biocad
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Neuromyelitis Optica Spectrum Disorders
Start date
2022-12-12
Primary completion
2025-01-01
Enrollment
105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.